Home
Archives
Jerusalem Center Homepage
View the current issue
Jerusalem Center Videos
Additional Resources
Top Commentators:
- Elliott Abrams
- Fouad Ajami
- Shlomo Avineri
- Benny Avni
- Alan Dershowitz
- Jackson Diehl
- Dore Gold
- Daniel Gordis
- Tom Gross
- Jonathan Halevy
- David Ignatius
- Pinchas Inbari
- Jeff Jacoby
- Efraim Karsh
- Mordechai Kedar
- Charles Krauthammer
- Emily Landau
- David Makovsky
- Aaron David Miller
- Benny Morris
- Jacques Neriah
- Marty Peretz
- Melanie Phillips
- Daniel Pipes
- Harold Rhode
- Gary Rosenblatt
- Jennifer Rubin
- David Schenkar
- Shimon Shapira
- Jonathan Spyer
- Gerald Steinberg
- Bret Stephens
- Amir Taheri
- Josh Teitelbaum
- Khaled Abu Toameh
- Jonathan Tobin
- Michael Totten
- Michael Young
- Mort Zuckerman
Think Tanks:
- American Enterprise Institute
- Brookings Institution
- Center for Security Policy
- Council on Foreign Relations
- Heritage Foundation
- Hudson Institute
- Institute for Contemporary Affairs
- Institute for Counter-Terrorism
- Institute for Global Jewish Affairs
- Institute for National Security Studies
- Institute for Science and Intl. Security
- Intelligence and Terrorism Information Center
- Investigative Project
- Jerusalem Center for Public Affairs
- RAND Corporation
- Saban Center for Middle East Policy
- Shalem Center
- Washington Institute for Near East Policy
Media:
- CAMERA
- Daily Alert
- Jewish Political Studies Review
- MEMRI
- NGO Monitor
- Palestinian Media Watch
- The Israel Project
- YouTube
Government:
Back
(Japan Daily Press) The Kameda Medical Center in Kamogawa City bought two systems worth $100,000, developed by Israeli company IceCure Medical Inc., to study their effectiveness in destroying cancerous lung tumors. The IceCure Medical system is based on the IceSense3, which was used to treat fibroadenoma breast tumors by injecting liquid nitrogen into the tumor. The system destroys the benign breast tumors without damaging the surrounding healthy tissues. The IceSense3 has already been approved in the U.S. and Europe. 2013-10-04 00:00:00Full Article
Japan to Test Israeli Cancer Treatment System
(Japan Daily Press) The Kameda Medical Center in Kamogawa City bought two systems worth $100,000, developed by Israeli company IceCure Medical Inc., to study their effectiveness in destroying cancerous lung tumors. The IceCure Medical system is based on the IceSense3, which was used to treat fibroadenoma breast tumors by injecting liquid nitrogen into the tumor. The system destroys the benign breast tumors without damaging the surrounding healthy tissues. The IceSense3 has already been approved in the U.S. and Europe. 2013-10-04 00:00:00Full Article
Search Daily Alert
|
Search:
|